Cancer, Breast Clinical Trial
Official title:
An Open-Label, Non-randomized, Multinational, Multi-center Phase I/Ⅱ Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
The primary objective of this phase I study is to evaluate the safety and potential efficacy and to determine the recommended phase 2 dose (RP2D) of CBP-1019, a bi-specific ligand conjugated drugs in patients with advanced solid tumors.
This phase Ia and Ib/II, open-label, multicenter study has two stages. The Ia stage is a dose-escalation study that will focus on safety, tolerability, pharmacokinetics, maximum tolerated dose (MTD) and phase 2 dose (RP2D). Patients with advanced solid tumor who failed from previous standard treatment or without standard therapy exists will be enrolled in the phase Ia study. Dose-limiting toxicity (DLT) observation period is 28 days. Patients in phase Ib/II part will be recruited into certain tumor cohorts and receive RP2D CBP-1019 iv infusion every two weeks. Primary efficacy of objective response rate (ORR), disease control rate (DCR), progression free survival (PFS), etc., will be evaluated. The correlation between tumor response and the receptors will be explored. Safety information will be collected in phase Ib/II stage. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04416087 -
Exercise and Tumor Blood Flow in Breast Cancer Patients
|
N/A | |
Active, not recruiting |
NCT04726319 -
Family History App in Personalized Medicine
|
N/A | |
Recruiting |
NCT05800834 -
Benefits of Morphine Gel for Pain Reduction in Patients With Cancer Wounds
|
Phase 2 | |
Completed |
NCT04692168 -
Influence of Chemotherapy on Postural Control in Women With Cancer
|
||
Recruiting |
NCT06152419 -
Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project
|
N/A | |
Recruiting |
NCT03709134 -
Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant Chemotherapy
|
||
Completed |
NCT03282214 -
A Self-Management Energy Conservation Program for Cancer-Related Fatigue
|
Phase 2 | |
Recruiting |
NCT06275321 -
Physical Exercise Benefits for Cancer Patients
|
N/A | |
Recruiting |
NCT05711030 -
Thoracic Paravertebral Block Anesthesia for Breast Cancer Surgery
|
N/A | |
Suspended |
NCT03271853 -
Thermalogical Analysis of a Cohort of Women and Men Undergoing Mammographic Analysis.
|
N/A | |
Active, not recruiting |
NCT03144947 -
Biomarker Study of Immune-mediated Mechanism of Action of Neoadjuvant Trastuzumab in HER2+ Breast Cancer Patients
|
Phase 2 | |
Completed |
NCT02996201 -
Electronic Patient Reporting of Side Effects to Chemotherapy: A Cluster Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT05573022 -
Impact of a Patient Decision Aid Intervention
|
N/A | |
Completed |
NCT05161312 -
A Guided Online Intervention to Improve Quality of Life in Breast Cancer Patients - a Randomised Clinical Trial
|
N/A | |
Completed |
NCT04836221 -
Comorbidities And Reducing inEquitieS
|
N/A | |
Recruiting |
NCT06345534 -
FAST-FORWARD vs HAI5
|
N/A | |
Recruiting |
NCT06391749 -
Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)
|
||
Enrolling by invitation |
NCT06409221 -
VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study
|
||
Not yet recruiting |
NCT03910283 -
Leveraging Mindsets to Improve Health & Wellbeing in Patients With Cancer
|
N/A | |
Completed |
NCT03612934 -
The Impact of SPC on Advanced Breast Cancer Patients
|